马拉维洛克
CCR5受体拮抗剂
趋化因子受体CCR5
C-C趋化因子受体6型
趋化因子受体
进入抑制剂
病毒进入
人类免疫缺陷病毒(HIV)
CXCR4型
化学
XCL2型
生物
趋化因子
受体
病毒学
病毒复制
生物化学
病毒
作者
Qiuxiang Tan,Ya Zhu,Jian Li,Zhuxi Chen,Gye Won Han,Irina Kufareva,Tingting Li,Limin Ma,Gustavo Fenalti,Jing Li,Wenru Zhang,Xin Xie,Huaiyu Yang,Hualiang Jiang,Vadim Cherezov,Hong Liu,Raymond C. Stevens,Qiang Zhao,Beili Wu
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2013-09-13
卷期号:341 (6152): 1387-1390
被引量:694
标识
DOI:10.1126/science.1241475
摘要
CCR5-Maraviroc Structure The chemokine receptor CCR5, a G protein–coupled receptor best known as a co-receptor during HIV-1 infection, is important in a variety of physiological processes. Tan et al. (p. 1387 , published online 12 September; see the Perspective by Klasse ) now report the high-resolution crystal structure of CCR5 bound to the HIV-1 entry inhibitor, Maraviroc. The structure suggests that Maraviroc acts as a noncompetitive inhibitor by binding to a region of CCR5 that is distinct from the binding site of HIV-1 and chemokines. Comparison of the structure of CCR5 with the other HIV-1 co-receptor, the chemokine receptor CXCR4, provides insight into the co-receptor selectivity of the virus.
科研通智能强力驱动
Strongly Powered by AbleSci AI